Anti-malarial antibodies that bind circumsporozoite protein
US11066464B2 · kind B2 · utility
1Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 11, 2018 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Jun 30, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.